Why CPAP and tirzepatide make good bedfellows: 2024 sleep conference highlights
What the latest evidence says about obstructive sleep apnoea, weight loss and cardiometabolic health
Tag: Obesity
As an endocrinologist specialising in obesity, I’m calling for a major rethink on how we manage this disease
For years, Andrew refused to see a GP. If he developed an infection, he’d often rely on his wife’s repeat antibiotic prescriptions. Andrew explains that…
TGA approves Mounjaro for weight loss amid global shortage
The TGA has approved tirzepatide, marketed as Mounjaro, for the treatment of obesity and overweight, even as the drug faces a global shortage. The dual…
Is semaglutide prescribing the reason bariatric surgeries are down?
Bariatric surgery numbers have fallen to their lowest level since 2016, with doctors saying the drop could reflect the use of non-surgical options like semaglutide…
Novo Nordisk finally launches semaglutide pen indicated for weight loss in Australia
Novo Nordisk’s subcutaneous weight-loss drug Wegovy will hit Australian shelves this month, two years after it received TGA approval. The once-weekly injectable semaglutide formulation will…
Abdominal fat rather than BMI alone ‘key to diagnosing obesity’
Patients with a BMI of ≥25kg/m2, a waist-to-height ratio of ≥0.5 and any medical complications should be diagnosed with obesity, according to a new clinical…
Semaglutide use linked to ischaemic optic neuropathy
Semaglutide is associated with non-arteritic anterior ischaemic optic neuropathy among patients with type 2 diabetes and those with overweight or obesity, according to a US…
Why doctors should be more open with patients about antidepressants and weight gain
When Dr Manfred Penzhorn prescribes antidepressants, he tells patients they are “almost certainly” about to put on weight. “Very few psychiatric medications don’t cause some…
GLP-1 RAs slapped with ileus warning after TGA investigation
New safety warnings about the risk of ileus have been added to all GLP-1 receptor agonists following a TGA investigation into local reports of the…
Watch for retained gastric contents with periprocedural GLP-1 RA use: new guidance
Patients taking GLP-1 receptor agonists within four weeks of anaesthesia for non-endoscopic procedures should be considered non-fasted, according to new guidance. Doctors are also advised…
